ABOS

Acumen Pharmaceuticals, Inc. Common Stock
Data: 2026-09-25
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Sep 25, 2026

49.8

AI Score

HOLD

0.58

Volume Ratio

Nov 11, 2026

Next Earnings

15

+ve Days (30d)

15

-ve Days (30d)

ABOS Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

ABOS Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

ABOS Options - Sort by Max open Interest (near term)

27th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABOS Daily Out of Money Options - Sort by Max open Interest (near term)

27th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABOS Daily In the Money Options - Sort by Max open Interest (near term)

27th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABOS Most Active Options by Volume(near term)

27th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track
ABOS Technical Chart Pro Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ABOS Stock Summary

Last updated Sep 25, 2026

ABOS is currently trading at $2.24, positioned below its 200-day moving average of $2.5, suggesting bearish momentum. The stock has a 52-week range of $1.3 to $3.6.

Technical Analysis: The 50-day moving average stands at $2.61, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 33.652, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.112, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ABOS at 49.8/100 with a HOLD recommendation.

ABOS (Acumen Pharmaceuticals, Inc. Common Stock) Indicators

Last updated Sep 25, 2026

Indicator Value
RSI(14) 33.652
CMF (20) -0.112
ROC (10) -23.288
ADX (14) 24.419
Indicator Value
MACD (12,26,9) -0.114
AROONOSC (14) -92.857
WILLAMS %R (14) -98.131
MFI (14) 22.271

ABOS Candlestick Patterns

Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.

Date Pattern Signal 5-Day Hit Rate Edge vs Baseline Sample
Sep 23 Marubozu (bearish) (contrarian — textbook says the opposite) Bullish 56.2% +3.2 pts 30540
Sep 15 Piercing Line (contrarian — textbook says the opposite) Bearish 50.5% +3.5 pts 4474

These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.

Acumen Pharmaceuticals, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

ABOS Moving Averages Analysis

ABOS (Acumen Pharmaceuticals, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Sep 25, 2026

Days MA
10 2.55
20 2.77
30 2.84
50 2.61
100 2.52
200 2.5

ABOS Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 161.6 million
Earnings/Share ($) -1.64
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -1.5891
EPS Estimate Next Year ($) -1.4328
WallStreet Target Price ($) 7.60
Most Recent Quarter

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.